S. Redenti

Pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidines and Structurally Simplified Analogs. Chemistry and SAR Profile as Adenosine Receptor Antagonists.

S. Moro, S. Federico, G. Spalluto, 2016, Current topics in medicinal chemistry.

Scaffold decoration at positions 5 and 8 of 1,2,4-triazolo[1,5-c]pyrimidines to explore the antagonist profiling on adenosine receptors: a preliminary structure-activity relationship study.

S. Moro, K. Klotz, S. Federico, 2014, Journal of medicinal chemistry.

A Triazolotriazine‐Based Dual GSK‐3β/CK‐1δ Ligand as a Potential Neuroprotective Agent Presenting Two Different Mechanisms of Enzymatic Inhibition

A. Cavalli, Maicol Bissaro, S. Moro, 2019, ChemMedChem.

A Self-degradable Curcumin Polymer with Anti-cancer Activity.

A. Jitianu, M. Sauane, L. Einbond, 2018, Journal of applied polymer science.

The Influence of the 1-(3-Trifluoromethyl-Benzyl)-1H-Pyrazole-4-yl Moiety on the Adenosine Receptors Affinity Profile of Pyrazolo[4,3-e][1,2,4]Triazolo[1,5-c]Pyrimidine Derivatives

M. Sturlese, S. Moro, K. Klotz, 2015, PloS one.

5,7-Disubstituted-[1,2,4]triazolo[1,5-a][1,3,5]triazines as pharmacological tools to explore the antagonist selectivity profiles toward adenosine receptors.

S. Moro, K. Klotz, S. Federico, 2016, European journal of medicinal chemistry.

Developing novel classes of protein kinase CK1δ inhibitors by fusing [1,2,4]triazole with different bicyclic heteroaromatic systems.

Maicol Bissaro, S. Moro, S. Federico, 2021, European journal of medicinal chemistry.